Welcome to Nightingale Health's investor pages
On our investor pages, you can read about Nightingale Health as an investment, find our latest releases and reports as well as follow Nightingale Health's share price development.
About Nightingale Health
Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. Nightingale Health has developed the world’s most advanced health check for the health industry. Our solution provides risk detection for multiple chronic diseases from a single blood sample.
Nightingale Health Check can be scaled to entire populations at a low cost, and it can replace many of the current risk assessments. Detecting disease risks on a population level allows for the effective targeting and tracking of health interventions, and better prevention of the onset of chronic diseases.
Contact us
ir@nightingalehealth.com
Latest releases
Inside Information: 23andMe and Nightingale Health Announce Strategic Collaboration to Pilot Blood Biomarker Panel
Inside information: Nightingale Health and Boston Heart Diagnostics enter strategic partnership to sell Nightingale’s Health Check in the United States
Nightingale Health and ZOE expand research collaboration to include self-collected blood samples
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Cor Group Oy)
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Pasi Soininen)
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Teemu Suna)
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Antti Kangas)
Health check based on advanced blood analysis technology builds a better foundation for public health
Nightingale Health’s Board of Directors extended the subscription period of employee option rights
Subscribe to releases.
Get the latest Nightingale Health releases delivered straight to your inbox.